Viewing Study NCT01641250


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-01-03 @ 8:06 PM
Study NCT ID: NCT01641250
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2012-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BP28085
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators